Journées de Biostatistique 2023

The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients

16 nov. 2023, 09:45

45m

Amphi Schwarz, 1R3 (Institut de Mathématiques de Toulouse)

Essais cliniques

Orateur

Dr Thomas Filleron (Oncopole Toulouse)